Lung Cancer News and Research

Latest Lung Cancer News and Research

Thalidomide does not improve survival in small cell lung cancer

Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, according to a new study published online July 16 in the Journal of the National Cancer Institute.

17 Jul 2009

Obama announces Regina Benjamin as Surgeon General pick

Dr. Regina Benjamin is President Obama's pick for surgeon general. The Alabama family physician has been an advocate for universal care, and is expected to have a role "at the table" in health reform, which would be an unusual degree of influence over policy for a surgeon general. Obama said Benjamin "represents what's best about health care in America."

15 Jul 2009

Dramatic drop in deaths from most common cancers

The death toll from three of the UK's most common cancers has dropped to its lowest level for almost 40 years* - according to new figures released by Cancer Research UK.

12 Jul 2009

Environmental manganese and cancer mortality rates

In the first ecological study of its kind in the world, a Wake Forest University Baptist Medical Center researcher has uncovered the unique finding that groundwater and airborne manganese in North Carolina correlates with cancer mortality at the county level.

9 Jul 2009

‘Roll-your-own’ cigarettes as deadly as ‘ready mades’

Roll-your-own (RYO) cigarettes expose smokers to similar levels of cancer-causing chemicals as manufactured cigarettes according to a new study by Cancer Research UK now published in Addiction Biology*.

6 Jul 2009

FDA approves Alimta (pemetrexed) for advanced lung cancer

The U.S. Food and Drug Administration has approved Alimta (pemetrexed), the first drug available for maintenance therapy of advanced or metastatic lung cancer.

6 Jul 2009

Researchers using microRNA to identify aggressive melanoma

Research at the University of Leicester will be breaking new ground in the search for a simple blood test that could tell whether a patient with melanoma has the condition in an aggressive form.

30 Jun 2009

Discovery of potent metastasis inhibitor

Researchers at Children's Hospital Boston have isolated a potent inhibitor of tumor metastasis made by tumor cells, one that could potentially be harnessed as a cancer treatment.

23 Jun 2009

Six 'major health agencies' form alliance to address chronic diseases in developing countries

A group of "major health agencies" from Australia, Canada, China, the U.K. and the U.S., which "together control 80 percent of the world's public health-research funding," have joined together to form the Global Alliance for Chronic Diseases (GACD) to combat chronic diseases in developing countries, Time reports (Walsh, Time, 6/16).

17 Jun 2009

Men hit by 'inexplicable' greater cancer death risk

Men are almost 40 per cent more likely than women to die from cancer, reveals a report published today (Monday) by the National Cancer Intelligence Network (NCIN) and Cancer Research UK together with the Men's Health Forum to mark Men's Health Week.

14 Jun 2009

Senate approves legislation to give the FDA power to regulate tobacco

The Senate overwhelmingly approved legislation today that gives the Food and Drug Administration regulatory power to limit nicotine in cigarettes, "drastically curtail" advertising and "ban candied tobacco products" aimed at the young, The Associated Press reports.

11 Jun 2009

Discovery of new angiogenesis protein - possible cancer drug target

To grow and spread, tumors need new blood vessels, a process called angiogenesis. One growth factor that causes angiogenesis has been identified - vascular endothelial growth factor or VEGF - and drugs to inhibit VEGF are already in use. But not all tumors respond to the therapy initially or over the long term. Thus new growth factors need to be identified to aid in developing the next generation of angiogenesis inhibitors.

9 Jun 2009

New lung cancer therapy with vaporized viral vector shows promise

A new lung cancer therapy employing a vaporized viral vector to deliver a cancer-inhibiting molecule directly to lung tissue shows early promise in mouse trials, according to researchers at the Ministry of Education, Science and Technology in Korea.

9 Jun 2009

Cremophor-based paclitaxel ‘chemo’ drug triggers fatal allergic reactions

A chemotherapy drug that is supposed to help save cancer patients' lives, instead resulted in life-threatening and sometimes fatal allergic reactions.

9 Jun 2009

Cisplatin doubles lung cancer survival time in mice

A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, according to Italian researchers.

9 Jun 2009

Report says 650,000 cancer deaths avoided between 1990 and 2005

The American Cancer Society's annual cancer statistics report finds that 15 years of steady declines in overall cancer death rates translate to about 650,000 deaths from cancer avoided or delayed during that time period. The estimate comes from 'Cancer Statistics 2009,' published early online and appearing in the July/August print issue of CA: A Cancer Journal for Clinicians.

4 Jun 2009

Prophylactic cranial irradiation prevents early lung cancer metastases to the brain

A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual meeting in Orlando, June 1.

3 Jun 2009

Research looks at relationship between death rates from lung cancer and how much a person smoked

It's common knowledge that smoking raises risks of lung cancer. And yet researchers haven't known whether continued smoking by lung cancer patients would increase the risk of the cancer's spread.

3 Jun 2009

Simple MRI test involving breathing oxygen helps determine cancer therapy success

A simple magnetic resonance imaging (MRI) test involving breathing oxygen might help oncologists determine the best treatment for some cancer patients, report researchers at UT Southwestern Medical Center.

3 Jun 2009

Vandetanib shows clinical benefit when combined with docetaxel for lung cancer

When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas M. D. Anderson Cancer Center.

1 Jun 2009